Publication | Open Access
Di‐n‐Butyl‐, Tri‐n‐Butyl‐ and Triphenyltin dl‐Terebates: Synthesis, Characterization and <i>In Vitro</i> Antitumour Activity
15
Citations
0
References
1997
Year
PathologyOrganic ChemistryReference CompoundsPharmaceutical ChemistryMedicinal ChemistryAnti-cancer AgentChemotherapyCancer ResearchBiochemistryOncogenic AgentMedicineTriphenyltin Dl‐terebatesCancer TreatmentPharmacologyNatural Product SynthesisTriphenyltin TerebatesNatural SciencesOncologyDerivative (Chemistry)Drug Discovery
Di-n-butyltin, tri-n-butyltin and triphenyltin terebates were screened against several human tumour cell lines and found comparably or more active than carboplatin, cis-platin, 5-fluorouracil, methotrexate and doxorubicin, some reference compounds used clinically.